Advances made in CAR-T immunotherapy to prevent relapse in multiple myeloma
A team from Clínic-IDIBAPS has introduced a modification to a CAR-T immunotherapy for multiple myeloma that makes it more durable, according to resul1
A team from Clínic-IDIBAPS has introduced a modification to a CAR-T immunotherapy for multiple myeloma that makes it more durable, according to resul1
Conducted as part of the MELCAYA project, the study demonstrates that anti PD-1 antibody immunotherapy is safe for children and adolescents. Furtherm1
Workers from IDIBAPS and other Campus Clínic organisations are eligible to take part. Each worker may submit a maximum of 3 photographs.
A team from the Clínic-IDIBAPS, the Institute of Neurosciences UBNeuro and the University of Barcelona led by Yaroslau Compta has participated in an1
Performing antitachycardia pacing (ATP) before a direct current shock to stop cardiac arrhythmias through an implanted defibrillator has certain limi1
Last week, IDIBAPS hosted the annual scientific meeting of the European Inter-Group for Childhood Non-Hodgkin Lymphoma (EICNHL). The event brought to1
Bipolar disorder is a chronic psychiatric condition characterised by the recurrent appearance of episodes of mania and depression interspersed with s1
Researchers at the Clínic-IDIBAPS and the Sanger Institute have taken an important step forward in understanding how genetic mutations expand in tiss1
Ten representatives of institutions based in Portugal, Poland, and Lithuania visited IDIBAPS from 11 to 15 November to participate in international p1
On Wednesday, 27 November, the CaixaResearch Institute, the research centre backed by Fundació ”la Caixa”, announced the first researchers to join i1